77 Breast Cancer Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Breast Cancer Studies in New York

NCT02620852Recruiting

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family history or genetics (except BRCA carriers) are recommended t...

New York, NYNA100,000 participantsUniversity of California, San Francisco

View Study Details

NCT06888388Recruiting

Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

Patients with a germline pathogenic variant (GPV) in high-penetrance breast cancer susceptibility genes who are considering risk reducing mastectomy (RRM) often strongly desire to keep their nipple ar...

New York, NY4,700 participantsSir Mortimer B. Davis - Jewish General Hospital

View Study Details

NCT05625659Recruiting

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

The over-arching goal of the Contrast-Enhanced Spectral Mammography Imaging Screening Trial (CMIST) is to determine if dual-energy contrast-enhanced spectral mammography (CESM) can detect more cancers...

New York, NYNA2,032 participantsAmerican College of Radiology

View Study Details

NCT07219277Recruiting

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

Breast cancer is the most common cancer that spreads beyond the initial layer of tissue it developed in, and grows into surrounding healthy tissue in women worldwide. It is associated with significant...

New York, NY2,000 participantsSyantra Inc.

View Study Details

NCT07308717Recruiting

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center....

New York, NYPHASE41,896 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06954337Recruiting

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-pe...

New York, NYNA1,750 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT02743858Recruiting

Lymphedema Surveillance Study

This study is being done to find out how many women develop lymphedema after an axillary lymph node dissection. The investigators also want to look for reasons why some women get lymphedema and others...

New York, NY1,250 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05561842Recruiting

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training rad...

New York, NY900 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06780176Recruiting

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer....

New York, NY800 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06275126Recruiting

Optimizing Surgical Decisions in Young Adults With Breast Cancer

The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evalua...

New York, NYNA800 participantsWeill Medical College of Cornell University

View Study Details

NCT07294703Recruiting

Factors Associated With Breast Cancer Risks and Outcomes

The purpose of this study is to learn more about risks and outcomes of breast cancer in people with different backgrounds. Tissue and blood will be collected from participants for research purposes. P...

New York, NY750 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06721065Recruiting

A Study of Language Interpretation Solutions for People With Breast Cancer

The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive M...

New York, NYNA700 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT00823654Recruiting

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

The purpose of this study is to learn more about the effects of your BRCA mutation on the ovaries. The BRCA gene can make it hard to conceive a child in the future. It may also bring on early menopaus...

New York, NY609 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT03572374Recruiting

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer ...

New York, NYNA546 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT01788839Recruiting

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

The purpose of this study is to see how cancer treatment affects sexual and reproductive function. The patient will also be asked to participate in blood draws to see if and how cancer treatment affec...

New York, NY475 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05867251Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

This study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-021 in patients...

New York, NYPHASE1430 participantsAvenzo Therapeutics, Inc.

View Study Details

NCT06334354Recruiting

A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

The purpose of this study is to look at how differences in cognitive (mental) function develop over time in breast cancer survivors compared to volunteers without a history of cancer (healthy voluntee...

New York, NY420 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06960707Recruiting

Two Versus One Week Breast Radiotherapy (RT)

This study is comparing two different radiation therapy approaches for early breast cancer to see which one is better for patients. One group will receive radiation over one week (based on the FAST-FO...

New York, NYPHASE3400 participantsWeill Medical College of Cornell University

View Study Details

NCT05134779Recruiting

De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You

This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease....

New York, NY400 participantsWeill Medical College of Cornell University

View Study Details

NCT07220967Recruiting

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

The researchers are doing this study to find out whether Stimulan Rapid Cure works to reduce the risk of infections in people getting tissue expanders placed during mastectomy. The researchers will al...

New York, NYPHASE4392 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05496829Recruiting

IMPACT Trial: Intervention to iMProve AdherenCe Equitably

To determine the efficacy of a multicomponent adherence intervention among participants with early-stage breast cancer on endocrine therapy and at least one oral cardiovascular disease (CVD) medicatio...

New York, NYNA350 participantsColumbia University

View Study Details

NCT07225309Recruiting

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

The purpose of this study is to find out if Meaning-Centered Psychotherapy for Latinos (MCP-L) helps reduce anxiety and depression and improves quality of life compared to cognitive behavioral therapy...

New York, NYNA300 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06144164Recruiting

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer....

New York, NYPHASE3285 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06726148Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Phase I: Characterize safety and tolerability of ECI830 as a single agent and in combination with ribociclib and fulvestrant. Identify dose range for optimization/recommended dose for future studies. ...

New York, NYPHASE1280 participantsNovartis Pharmaceuticals

View Study Details

NCT04084730Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

The purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that cause...

New York, NYPHASE2280 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05856773Recruiting

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

The purpose of this research study is to learn more about the effects of using proton radiation therapy delivered over a shorter course of treatment (3 weeks) compared with a longer, standard course o...

New York, NYPHASE3276 participantsProton Collaborative Group

View Study Details

NCT06134375Recruiting

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

There are two parts to this study. It is a phase 1b followed by a randomized phase 2 study to assess whether adding 3 years of adjuvant tetrathiomolybdate (TM) to standard 6 months treatment of adjuva...

New York, NYPHASE1204 participantsDartmouth-Hitchcock Medical Center

View Study Details

NCT06099769Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor...

New York, NYPHASE2201 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05351424Recruiting

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster recep...

New York, NYNA194 participantsColumbia University

View Study Details

NCT05508906Recruiting

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

This is a Phase 1b open-label, 2-part study in 3 treatment groups. The 3 treatment groups are as follows: Treatment Group 1: Palazestrant (OP-1250) in combination with ribociclib (KISQALI®, Novartis ...

New York, NYPHASE1190 participantsOlema Pharmaceuticals, Inc.

View Study Details

NCT05898399Recruiting

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients

This interventional study will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ART6043 as monotherapy or in combination with Olaparib or Niraparib....

New York, NYPHASE1181 participantsArtios Pharma Ltd

View Study Details

NCT07053085Recruiting

A Study of Surgery and Radiotherapy in People With Breast Cancer

The researchers are doing this study to see if the combination of surgery, locoregional radiation therapy, SBRT (stereotactic body radiation therapy), and the usual approach is more effective in treat...

New York, NYPHASE2178 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07483307Recruiting

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

The purpose of this study is to look at how effective neoadjuvant (before surgery) endocrine therapy (NET) is in participants with invasive lobular carcinoma (ILC) who have breast-conserving surgery (...

New York, NYPHASE2176 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05592938Recruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Breast-conserving surgery followed by re-irradiation with partial breast irradiation (rPBI) has recently been found to be a safe alternative to mastectomy for women who have undergone prior whole brea...

New York, NYNA171 participantsUniversity Health Network, Toronto

View Study Details

NCT03351348Recruiting

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

The purpose of this study is to compare using FDA-approved bupivacaine (a numbing medicine), along with the usual medications for post-operative pain control to using the usual medications for postope...

New York, NYPHASE3165 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04458532Recruiting

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

This study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes/session) over different periods of time (number of weeks). Aerobic ex...

New York, NYNA152 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05716893Recruiting

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

In this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will a...

New York, NYPHASE2140 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT01766297Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

The purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy. This study is being done to see if proton radiation therapy will ...

New York, NYPHASE2132 participantsProton Collaborative Group

View Study Details

NCT07335354Recruiting

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast rec...

New York, NYNA131 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06037954Recruiting

A Study of Mental Health Care in People With Cancer

The purpose of this study is to look at mental health services for adults with depressed mood who were diagnosed with cancer at the age of 65 or older. This study will compare the usual approach for c...

New York, NYNA130 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04371913Recruiting

Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study

The goal of the study is to investigate the feasibility of enabling a second chance for breast conservation in patients with in-breast recurrences after a previous lumpectomy and RT, investigators pro...

New York, NYNA120 participantsWeill Medical College of Cornell University

View Study Details

NCT02772367Recruiting

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

The purpose of this study is to investigate whether cells from a biopsy taken from the patient skin can be transformed into cardiomyocytes the changes in cardiomyocyte (heart muscle cells) when grown ...

New York, NY120 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04563507Recruiting

Combined Immunotherapies in Metastatic ER+ Breast Cancer

Women with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (HER)2- metastatic breast cancer are eligible to a randomized trial. Patients receiving standard first line therapy for metasta...

New York, NYPHASE2102 participantsWeill Medical College of Cornell University

View Study Details

NCT03804944Recruiting

Converting HR+ Breast Cancer Into an Individualized Vaccine

Newly diagnosed post-menopausal women with clinical stage II-III, HR+HER2- breast cancer are eligible to a randomized trial, concurrently open at five US academic institutions. Patients receiving 4 mo...

New York, NYPHASE2100 participantsWeill Medical College of Cornell University

View Study Details

NCT07635147Recruiting

Decision Support Tool for Patients With Advanced Breast Cancer

The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part ...

New York, NYNA100 participantsWeill Medical College of Cornell University

View Study Details

NCT05590949Recruiting

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

The purpose of this study to gather information about changes in the bones after stopping treatment with aromatase inhibitor/AI and denosumab. The study team will collect information from 5 standard c...

New York, NY100 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07205822Recruiting

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

A study to assess the efficacy and safety of Dato-DXd in the pre-chemotherapy setting for patients with metastatic HR-positive, HER2 IHC 0 breast cancer....

New York, NYPHASE3100 participantsAstraZeneca

View Study Details

NCT05438511Recruiting

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process....

New York, NY85 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT02926690Recruiting

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

The purpose of this study is to determine the maximum tolerated dose (MTD) of OTS167 administered via oral capsule (PO) to patients with relapsed/refractory locally advanced or metastatic breast cance...

New York, NYPHASE170 participantsOncoTherapy Science, Inc.

View Study Details

NCT06405828Recruiting

Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer

Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a communit...

New York, NYNA67 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT07042581Recruiting

A Study of Revaree Plus in People With Breast Cancer

The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment....

New York, NYPHASE460 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05412225Recruiting

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

The purpose of this study to test an alternative treatment approach that involves giving participants radiotherapy before their mastectomy (preoperative radiotherapy) and performing immediate reconstr...

New York, NYPHASE160 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07459673Recruiting

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

Thie purpose of this study is to find out whether a personalized treatment approach-using a series of ctDNA tests along with standard imaging scans to help decide when to step up (escalate) or decreas...

New York, NYPHASE260 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05422794Recruiting

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

This phase Ib trial tests the safety and tolerability of ZEN003694 in combination with an immunotherapy drug called pembrolizumab and the usual chemotherapy approach with nab-paclitaxel for the treatm...

New York, NYPHASE157 participantsNational Cancer Institute (NCI)

View Study Details

NCT06110793Recruiting

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

The purpose of this study is to test whether the combination of lenvatinib, pembrolizumab, and fulvestrant is a safe and effective treatment that causes few or mild side effects in people with ER+/HER...

New York, NYPHASE156 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05130801Recruiting

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

The purpose of this study is to find out whether pre-operative mpMRI using additional MRI sequences may improve surgical outcomes by providing more accurate information about the extent and acidity of...

New York, NYPHASE155 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05570253Recruiting

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

The researchers are doing this study to find out whether the study drug, SDX-7320, when combined with the standard chemotherapy eribulin, is an effective treatment for people with TNBC and metabolic d...

New York, NYPHASE255 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06908928Recruiting

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

The goal of this clinical trial is to investigate if treatment with bulumtatug fuvedotin is effective in triple-negative breast cancer patients who have previously received treatment with an antibody-...

New York, NYPHASE152 participantsMabwell (Shanghai) Bioscience Co., Ltd.

View Study Details

NCT04824027Recruiting

Breast Elasticity Imaging During Neoadjuvant Chemotherapy

For this study, the investigators propose investigation of a new imaging technique, Harmonic Motion Imaging (HMI), and the evaluation of its potential role in prediction of breast cancer response to n...

New York, NYNA50 participantsColumbia University

View Study Details

NCT07612215Recruiting

Elacestrant in Advanced Triple Positive Breast Cancer

The purpose of this study to assess the safety and efficacy of elacestrant, a selective estrogen receptor degrader (SERD) and dual biologic therapy, trastuzumab and pertuzumab, in patients with triple...

New York, NYPHASE150 participantsNYU Langone Health

View Study Details

NCT05534438Recruiting

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

The purpose of this study is to see if using Stereotactic Body Radiation Therapy/SBRT to treat a single metastatic site where cancer has worsened may be an effective treatment for people with oligomet...

New York, NYPHASE246 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06127979Recruiting

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

The researchers are doing this study to look at changes in Ki67 expression after at least 2 weeks of endocrine therapy in people with ER+/HER2- breast cancer undergoing cancer removal surgery. Partici...

New York, NYNA42 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05095207Recruiting

Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

This is an open label multicenter, Phase IB/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer...

New York, NYPHASE142 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT03449238Recruiting

Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

Patients with metastatic breast cancer with at least 2 brain metastases will receive pembrolizumab every 3 weeks. Patients will undergo stereotactic radiosurgery (SRS) to one of the brain lesions. Pem...

New York, NYPHASE141 participantsWeill Medical College of Cornell University

View Study Details

NCT04683679Recruiting

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

The purpose of this study is to find out whether adding pembrolizumab, with or without olaparib, to standard radiation therapy is a safe and effective treatment for metastatic breast cancer, , and to ...

New York, NYPHASE234 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06927895Recruiting

Breast Cancer Implementation Science Study With Educational Intervention

A study uniquely focused on system-based practice change, measuring the impact of educational interventions on both patients and clinicians for the recognition and management of treatment-related adve...

New York, NYNA30 participantsNYU Langone Health

View Study Details

NCT07711847Recruiting

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

The goal of this clinical trial is to find out whether using a personalized breast holder (called VENUS SHELL™) can improve positioning and patient comfort during prone radiotherapy (radiotherapy give...

New York, NYNA30 participantsHeroSupport SA

View Study Details

NCT03990896Recruiting

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 or BRCA 2 mutation....

New York, NYPHASE230 participantsMassachusetts General Hospital

View Study Details

NCT06246968Recruiting

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

Participants will have a confirmed diagnosis of metastatic breast cancer and will receive pembrolizumab in combination with cryoablation OR pembrolizumab alone. Participants will be randomly assigned....

New York, NYPHASE130 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06678269Recruiting

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

The purpose of this study is to test different doses of abemaciclib to find the best dose in participants while receiving hormone therapy and radiation therapy....

New York, NYPHASE128 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07192432Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

This is a Phase 1/2, first-in-human, open-label, dose-escalating and expansion trial designed to assess the safety and efficacy of VNX-202 in patients with HER2 positive cancers....

New York, NYPHASE127 participantsVironexis Biotherapeutics Inc.

View Study Details

NCT05837767Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

The purpose of this study is to find out whether lattice radiation therapy (LRT) is an effective radiation therapy technique when compared to standard stereotactic body radiation therapy (SBRT). The s...

New York, NYNA26 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07218250Recruiting

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer

The purpose of this study is to see if a Single Counseling Session for Cancer can help reduce psychosocial distress and improve quality of life in people with breast cancer who are waiting to receive ...

New York, NYNA26 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04997993Recruiting

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

Leflunomide in patients with PTEN-Altered advanced solid tumors or HER2 negative breast cancer. Phase 1A objectives are to determine the safety, tolerability, and the MTD of leflunomide in patients wi...

New York, NYPHASE123 participantsDeborah Doroshow

View Study Details

NCT06072807Recruiting

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

The goal of this interventional study is to optimize the protocol of FES PET/CT in Estrogen Receptor positive Breast cancer patients with Brain metastases. Patients will undergo MRI of the brain and F...

New York, NYPHASE420 participantsWeill Medical College of Cornell University

View Study Details

NCT06637306Recruiting

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Pilot trial of the IL-4 receptor antagonist dupilumab plus pembrolizumab, paclitaxel, and carboplatin in locally advanced triple negative breast cancer (TNBC). Primary Objective: To assess the safety...

New York, NYEARLY_PHASE115 participantsRima Patel

View Study Details

NCT06673329Recruiting

Brodalumab in the Treatment of Immune-Related Adverse Events

The purpose of this study is to test the safety and effectiveness of using brodalumab in patients who develop side effects from cancer immune therapy. Immune-related side effects are due to activation...

New York, NYPHASE111 participantsBrian Henick, MD

View Study Details

About Breast Cancer Clinical Trials in New York

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 77 breast cancer clinical trials recruiting participants in New York, NY. These studies are seeking a combined 127,386 participants. Research is being sponsored by University of California, San Francisco, Sir Mortimer B. Davis - Jewish General Hospital, American College of Radiology and 23 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in New York — FAQ

Are there breast cancer clinical trials in New York?

Yes, there are 77 breast cancer clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 77 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 18, 2026 from ClinicalTrials.gov